IRIS
CALZETTA, LUIGINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 47.054
AS - Asia 7.855
EU - Europa 5.071
SA - Sud America 1.109
AF - Africa 84
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 13
Totale 61.209
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 46.875
SG - Singapore 3.782
CN - Cina 1.304
IT - Italia 1.004
BR - Brasile 904
RU - Federazione Russa 835
HK - Hong Kong 812
IE - Irlanda 655
VN - Vietnam 606
KR - Corea 539
UA - Ucraina 513
FR - Francia 462
DE - Germania 440
PL - Polonia 307
GB - Regno Unito 248
FI - Finlandia 230
JP - Giappone 187
BD - Bangladesh 177
SE - Svezia 120
IN - India 104
CA - Canada 98
NL - Olanda 82
ID - Indonesia 71
AR - Argentina 67
ES - Italia 44
MX - Messico 35
IQ - Iraq 34
EC - Ecuador 33
PK - Pakistan 29
ZA - Sudafrica 29
TR - Turchia 28
AT - Austria 26
CO - Colombia 25
UZ - Uzbekistan 24
BE - Belgio 23
VE - Venezuela 23
MY - Malesia 21
AU - Australia 18
CL - Cile 18
PH - Filippine 17
TW - Taiwan 16
PE - Perù 15
EG - Egitto 14
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
IL - Israele 11
JO - Giordania 11
LT - Lituania 11
MA - Marocco 11
SA - Arabia Saudita 11
GR - Grecia 10
PT - Portogallo 10
RO - Romania 10
TH - Thailandia 10
A2 - ???statistics.table.value.countryCode.A2??? 9
CR - Costa Rica 9
IR - Iran 9
UY - Uruguay 9
NP - Nepal 7
PA - Panama 7
DZ - Algeria 6
HU - Ungheria 6
JM - Giamaica 6
KZ - Kazakistan 6
TN - Tunisia 6
AL - Albania 5
KE - Kenya 5
NZ - Nuova Zelanda 5
AZ - Azerbaigian 4
CH - Svizzera 4
ET - Etiopia 4
EU - Europa 4
KH - Cambogia 4
MK - Macedonia 4
NI - Nicaragua 4
RS - Serbia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
OM - Oman 3
SY - Repubblica araba siriana 3
BH - Bahrain 2
BO - Bolivia 2
GA - Gabon 2
GE - Georgia 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
NO - Norvegia 2
PR - Porto Rico 2
SN - Senegal 2
AM - Armenia 1
BS - Bahamas 1
BZ - Belize 1
CY - Cipro 1
Totale 61.195
Salva come PNG Salva come JPEG
Città #
Wilmington 11.606
Houston 11.249
Woodbridge 10.252
Fairfield 1.944
Singapore 1.691
Ashburn 1.139
Ann Arbor 989
San Jose 905
Seattle 807
Hong Kong 794
Chandler 749
Cambridge 669
Dublin 567
Beijing 427
Medford 422
Jacksonville 351
Council Bluffs 343
Dearborn 325
Santa Clara 298
Kraków 280
Rome 250
The Dalles 246
New York 243
Los Angeles 223
Ho Chi Minh City 209
Lawrence 195
Lauterbourg 172
Tokyo 164
Hanoi 153
Moscow 139
Boardman 138
Colorado Springs 129
Zhengzhou 119
San Diego 118
Buffalo 113
Helsinki 109
Chicago 103
Dallas 102
São Paulo 98
Monte Vista 95
Milan 77
Menlo Park 74
Naples 69
London 49
Norwalk 44
Redondo Beach 43
Jakarta 40
North Bergen 39
Nuremberg 39
Redwood City 39
Shanghai 39
Guangzhou 35
Toronto 33
Phoenix 30
Frankfurt am Main 29
Orem 29
Salt Lake City 29
Rio de Janeiro 28
Nanjing 27
Hangzhou 26
Brooklyn 24
Hefei 24
Mountain View 24
Verona 23
Columbus 22
Lappeenranta 22
Palo Alto 22
Belo Horizonte 21
Brussels 20
Haiphong 20
Tashkent 20
Warsaw 20
Atlanta 19
Chennai 19
Denver 19
Elk Grove Village 18
Munich 18
Da Nang 17
Kunming 17
Mülheim 17
Stockholm 17
Brasília 16
Chengdu 16
Detroit 16
Jinan 16
Parma 16
Poplar 16
Saint Petersburg 16
Montreal 15
San Francisco 15
Seoul 15
Tampa 15
Turin 15
Baghdad 14
Johannesburg 14
Charlotte 13
Curitiba 13
Mumbai 13
Philadelphia 13
Salvador 13
Totale 50.446
Salva come PNG Salva come JPEG
Nome #
Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells 512
Asthma and COPD in an Italian adult population: Role of BMI considering the smoking habit 508
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis 508
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 503
Interaction between corticosteroids and muscarinic antagonists in human airways 503
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis 498
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? 490
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond 488
Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD 485
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD 485
A Novel and Effective Balanced Intravenous-Inhalant Anaesthetic Protocol in Swine by Using Unrestricted Drugs 484
Glucagon-like peptide 1 receptor: A novel pharmacological target for treating human bronchial hyperresponsiveness 484
Asthma and comorbid medical illness. 481
Optimizing drug delivery in COPD: The role of inhaler devices 479
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside 478
LABA/LAMA combination in copd: A meta-analysis on the duration of treatment 476
Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation 475
Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells 469
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 468
High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. 466
Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update 464
Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases 463
Occupational allergy to horse allergens: More than exposure to horses! 458
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis 458
Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis 452
Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents? 448
Umeclidinium for the treatment of chronic obstructive pulmonary disease 447
Can pet keeping be considered the only criterion of exposure to cat/dog allergens in the first year of life? 447
Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients 446
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease 446
Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma? 446
The prevalence of asthma and COPD in Italy: a practice-based study 442
Tiotropium formulations and safety: a network meta-analysis 441
Asthma and comorbid medical illness 439
Effects of chronic treatment with the new ultra-long-acting β2-adrenoceptor agonist indacaterol alone or in combination with the β1-adrenoceptor blocker metoprolol on cardiac remodelling 433
How many systemic reactions to skin prick tests could be preventable in defined conditions? 433
Is allergic sensitization to siberian hamster preventable in high-risk individuals who are already sensitized or exposed to furry animals? 433
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD 432
Is H1-antihistamine (desloratadine 5 mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in “real life”? 431
Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study 430
The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils 430
Clinical effect of corticosteroids in asthma-affected horses: A quantitative synthesis 430
Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD 430
The Challenges of Precision Medicine in COPD 429
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways 428
New Treatments for COPD in the Elderly 427
Dog allergen immunotherapy and allergy to furry animals 426
The effect of indacaterol during an acute exacerbation of COPD 424
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 424
Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi 423
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi 422
Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi 420
Translational study searching for synergy between glycopyrronium and indacaterol 420
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis 419
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study 418
Comorbidities of asthma 416
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi 416
Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008 415
The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease 415
Can the presence of cat/dog at home be considered the only criterion of exposure to cat/dog allergens? A likely underestimated bias in clinical practice and in large epidemiological studies 415
Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi 413
Brensocatib: Dipeptidyl peptidase 1 (DPP1) inhibitor Treatment of non-cystic fibrosis bronchiectasis 413
Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity 412
The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle. 412
Letter to the Editor: Can dog allergen immunotherapy reduce concomitant allergic sensitization to other furry animals? A preliminary experience 411
Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone 406
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis 400
Is the risk of developing atopic sensitization and bronchial asthma in animal laboratory workers preventable in well-defined susceptible individuals? 398
What could the role of can f 5 allergen be in dog-sensitized patients in “real life”? 396
Critical aspects in dog allergen immunotherapy (DAI). May Component Resolved Diagnosis (CRD) play a role in predicting the efficacy? 393
Combining long-acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airways 393
Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens 392
Chronic cat allergen exposure and low sensitization: Possible limitations in patient selection? 390
Gastroesophageal reflux and COPD exacerbations: Is cholinergic-mediated oesophago-bronchial reflex a possible link? 390
Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics 390
The clinical use of regenerative therapy in COPD 390
Partial nephrectomy using radiofrequency incremental bipolar generator with multi electrode probe: experimental study in bench pig kidneys 385
Partial renal resection by LaparoNewPro: in vivo open and laparoscopic study in an animal model 380
Diabetes mellitus among outpatients with COPD attending a university hospital. 375
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study 375
Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine 374
Brain natriuretic peptide protects against hyperresponsiveness of human asthmatic airway smooth muscle via an epithelial cell-dependent mechanism 373
Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways 373
Relationship between oxytocin/vasopressin and latex in obstetric surgery: How to recognize (and prevent) allergic reactions and differentiate them from side effects? 371
Anaphylaxis and intimate behaviour 369
Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue 363
Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus 362
Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchi 361
Anxiety and asthma in youth. Is a stress-induced increased cholinergic tone the possible link? 361
Brain natriuretic peptide: Much more than a biomarker 358
Phosphodiesterase inhibitors for chronic obstructive pulmonary disease: what does the future hold? 357
Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis 356
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis 356
Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi 354
Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma 351
Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how 347
Canakinumab for the treatment of chronic obstructive pulmonary disease 334
Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi 326
Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008 322
Is ICS–LAMA an alternative option to treat patients with COPD? 318
Totale 42.076
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 0 0 109
2021/20221.892 126 173 30 31 54 186 218 76 115 203 182 498
2022/20232.109 264 148 60 236 167 537 205 126 199 14 91 62
2023/2024928 196 23 59 16 62 145 68 118 37 52 19 133
2024/20255.702 163 1.180 601 286 187 228 485 263 488 626 624 571
2025/20269.293 588 480 1.011 695 1.074 429 1.212 1.108 1.182 650 547 317
Totale 62.037